Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
International Journal of Molecular Sciences|May 14, 2022
Generation of Cancer Stem/Initiating Cells by Cell-Cell FusionThomas DittmarCancer Immunology, Immunotherapy : CII|March 23, 2004
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytesJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.Seminars in Cancer Biology|February 6, 2008
The cancer's nervous tooth: Considering the neuronal crosstalk within tumorsFrank Entschladen, Daniel Palm, Bernd Niggemann, et al.Journal of Periodontology|September 3, 2009
Influence of enamel matrix derivative on primary CD4+ T-helper lymphocyte migration, CD25 activation, and apoptosisGeorg Gassmann, Bettina Schwenk, Frank Entschladen, et al.International Journal of Cancer|July 13, 2002
Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loopKerstin Lang, Bernd Niggemann, Kurt S Zanker, et al.Cancer Research|November 20, 2002
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cellsJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.Cancer Immunology, Immunotherapy : CII|January 26, 2006
Tumor immune escape mechanisms: impact of the neuroendocrine systemKerstin Lang, Frank Entschladen, Corinna Weidt, et al.Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.Current Pharmaceutical Design|October 25, 2014
Anti-metastatics: an overview of drug candidates in current pipelinesAnne Schaap-Nutt, Dane A Thyssen, David W Drell, et al.Cell Communication and Signaling : CCS|July 15, 2010
PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironmentMelanie J Voss, Bernd Niggemann, Kurt S Zänker, et al.Pageof 13